For: | Chong CCN, Wong GLH, Lai PBS. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 6006-6012 [PMID: 24876723 DOI: 10.3748/wjg.v20.i20.6006] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/6006.htm |
Number | Citing Articles |
1 |
Pin-Gao Yan, Ruo-Yu Wang, Jin Zhang, Wen-Ming Cong, Hui Dong, Hong-Yu Yu, Wan Yee Lau, Meng-Chao Wu, Wei-Ping Zhou. Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients—a Retrospective Study. Journal of Gastrointestinal Surgery 2018; 22(5): 872 doi: 10.1007/s11605-017-3638-0
|
2 |
Xueli Zhang, Liang Wang, Haitao Zhang, Fang Tu, Yong Qiang, Cuifang Nie. Decreased expression of ZO‑1 is associated with tumor metastases in liver cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.9765
|
3 |
Chuan Chen, Dong-Ping Chen, Yan-Yan Gu, Liang-Hao Hu, Dan Wang, Jin-Huan Lin, Zhao-Shen Li, Jing Xu, Ge Wang. Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?. Tumor Biology 2015; 36(8): 6255 doi: 10.1007/s13277-015-3311-8
|
4 |
Xinye Qian, Yun Wang, Wang Hu, Xiaolei Xu, Lu Gao, Yongchang Meng, Jun Yan. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression. Tissue and Cell 2022; 74: 101721 doi: 10.1016/j.tice.2021.101721
|
5 |
Chao-Wei Lee, Hsin-I Tsai, Chang-Mu Sung, Chun-Wei Chen, Shu-Wei Huang, Wen-Juei Jeng, Tsung-Han Wu, Kun-Ming Chan, Ming-Chin Yu, Wei-Chen Lee, Miin-Fu Chen. Risk factors for early mortality after hepatectomy for hepatocellular carcinoma. Medicine 2016; 95(39): e5028 doi: 10.1097/MD.0000000000005028
|
6 |
Zong-yan Wang, Qi-fei Tao, Zhi-heng Wang, Kong-ying Lin, Gang Huang, Yuan Yang, Wei-ping Zhou, Wan Yee Lau. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm – A retrospective cohort study. The American Journal of Surgery 2020; 219(4): 717 doi: 10.1016/j.amjsurg.2019.05.016
|
7 |
G. L.‐H. Wong, V. W.‐S. Wong. Letter: which patients with hepatitis B virus‐related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy? Authors' reply. Alimentary Pharmacology & Therapeutics 2016; 44(8): 910 doi: 10.1111/apt.13778
|
8 |
Maowen Yu, Chaozhu Zhang, Hongbo Tang, Chaohui Xiao, Hangjun Che. Correlation between Serum Oxidative Stress Level and Serum Uric Acid and Prognosis in Patients with Hepatitis B-Related Liver Cancer before Operation. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/1964866
|
9 |
Aimin Li, Qun Yan, Xinmei Zhao, Jietao Zhong, Haiyun Yang, Zhiqiang Feng, Yanlei Du, Yadong Wang, Zenan Wang, Hong Wang, Yongjian Zhou, Side Liu, Yuqiang Nie. Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma. Oncotarget 2016; 7(1): 524 doi: 10.18632/oncotarget.6358
|
10 |
Ming-Da Wang, Hao Xing, Chao Li, Lei Liang, Han Wu, Xin-Fei Xu, Li-Yang Sun, Meng-Chao Wu, Feng Shen, Tian Yang. A novel role of Krüppel-like factor 8 as an apoptosis repressor in hepatocellular carcinoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01513-3
|
11 |
Mu‐xing Li, Hong Zhao, Xin‐yu Bi, Zhi‐yu Li, Zhen Huang, Yue Han, Jian‐guo Zhou, Jian‐jun Zhao, Ye‐fan Zhang, Jian‐qiang Cai. Prognostic value of the albumin–bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort. Hepatology Research 2017; 47(8): 731 doi: 10.1111/hepr.12796
|
12 |
Vicki Wing-Ki Hui, Stephen Lam Chan, Vincent Wai-Sun Wong, Lilian Yan Liang, Terry Cheuk-Fung Yip, Jimmy Che-To Lai, Becky Wing-Yan Yuen, Hester Wing-Sum Luk, Yee-Kit Tse, Hye-Won Lee, Henry Lik-Yuen Chan, Grace Lai-Hung Wong. Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC. JHEP Reports 2020; 2(6): 100152 doi: 10.1016/j.jhepr.2020.100152
|
13 |
Kuan-Chun Hsueh, Ting-Ying Lee, Chew-Teng Kor, Tsung-Ming Chen, Tzu-Ming Chang, Shun-Fa Yang, Chung-Bao Hsieh. The role of liver transplantation or resection for patients with early hepatocellular carcinoma. Tumor Biology 2016; 37(3): 4193 doi: 10.1007/s13277-015-4243-z
|
14 |
Xiao-Jun Lin, Xiang-Ming Lao, Ming Shi, Sheng-Ping Li. Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment. Digestive Diseases and Sciences 2016; 61(9): 2465 doi: 10.1007/s10620-016-4167-5
|
15 |
Zhi‐Bo Xie, Shao‐Liang Zhu, Yu‐Chong Peng, Jie Chen, Xiao‐Bo Wang, Liang Ma, Tao Bai, Bang‐De Xiang, Le‐Qun Li, Jian‐Hong Zhong. Postoperative hepatitis B virus reactivation and surgery‐induced immunosuppression in patients with hepatitis B‐related hepatocellular carcinoma. Journal of Surgical Oncology 2015; 112(6): 634 doi: 10.1002/jso.24044
|
16 |
Teng‐Yu Lee, Jaw‐Town Lin, Yi‐Siou Zeng, Yi‐Ju Chen, Ming‐Shiang Wu, Chun‐Ying Wu. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus–related hepatocellular carcinoma after radiofrequency ablation. Hepatology 2016; 63(5): 1517 doi: 10.1002/hep.28266
|